It is a common misconception that buffer outsourcing is only beneficial in large-scale biomanufacturing.
Yes, outsourcing buffer preparation is advantageous for large-scale operations, but it also has its place in smaller processes e.g. in research or cell and gene therapy applications.
Particularly with the rapid upturn in cell and gene therapy processes in development, it’s time you considered what you could gain from outsourcing buffer when your batch size is smaller:
It keeps organisations capital-lean
It enables companies to maximize their limited resources most effectively
It lays the groundwork for easy scale-up
It provides an assurance of supply
Now thinking about outsourcing your buffer preparation? To help navigate the decision-making process, read our whitepaper or speak to one of the team.
Leave a Reply